|
GFPT1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.961300E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.797150E-03 |
| Normal-vs-Stage2 |
7.607700E-02 |
| Normal-vs-Stage3 |
1.404730E-03 |
| Normal-vs-Stage4 |
7.178400E-04 |
| Stage1-vs-Stage2 |
6.977400E-01 |
| Stage1-vs-Stage3 |
4.069800E-01 |
| Stage1-vs-Stage4 |
3.787600E-01 |
| Stage2-vs-Stage3 |
3.832200E-01 |
| Stage2-vs-Stage4 |
3.613400E-01 |
| Stage3-vs-Stage4 |
9.943600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.323700E-03 |
| Normal-vs-AfricanAmerican |
1.83809999998452E-07 |
| Normal-vs-Asian |
7.368600E-01 |
| Caucasian-vs-AfricanAmerican |
6.847600E-04 |
| Caucasian-vs-Asian |
4.453400E-01 |
| AfricanAmerican-vs-Asian |
2.293700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.18969999999929E-05 |
| Normal-vs-Female |
1.104960E-01 |
| Male-vs-Female |
7.979400E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.191500E-04 |
| Normal-vs-Age(41-60Yrs) |
6.846500E-04 |
| Normal-vs-Age(61-80Yrs) |
7.060000E-03 |
| Normal-vs-Age(81-100Yrs) |
4.775800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.732200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.503600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.305800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.357400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.383000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.015000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.777600E-02 |
| Normal-vs-Grade 2 |
1.862110E-02 |
| Normal-vs-Grade 3 |
6.44129999999299E-05 |
| Normal-vs-Grade 4 |
1.792430E-04 |
| Grade 1-vs-Grade 2 |
6.681400E-01 |
| Grade 1-vs-Grade 3 |
8.258600E-01 |
| Grade 1-vs-Grade 4 |
6.962800E-01 |
| Grade 2-vs-Grade 3 |
5.693800E-02 |
| Grade 2-vs-Grade 4 |
5.983900E-02 |
| Grade 3-vs-Grade 4 |
7.694200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.238590E-01 |
| Normal-vs-ccB subtype |
1.175110E-03 |
| ccA subtype-vs-ccB subtype |
3.001900E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.004800E-03 |
| Normal-vs-N1 |
8.410600E-01 |
| N0-vs-N1 |
2.603800E-01 |
|
|
